CellTrans has claimed the first FDA approval for a cell therapy used to treat type 1 diabetes, consisting of insulin-producing islet beta cells taken from deceased donors. The Chicago-based ...

While genetics studies have identified mutations that increase the risk of developing type 1 diabetes, the gene pool alone cannot fully explain who is susceptible to the disease. Altindis and ...

Vertex Pharma has made its name with treatment for cystic fibrosis, but has big plans in cell and genetic ... therapy for diabetes. VX-880 (formerly known as STx-02) derives from Vertex’ near $1 ...

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if ...

Researchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially ...

Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and ...

A record entirely from the South, in a sector that has always been a thorn in the side. At the University Hospital of Palermo ...

Patients with the debilitating dermatologic condition are born with COL7A1 mutations in both gene copies, affecting the ...

Researchers at the University of Queensland have found that improving the function of the gut microbiome may delay the onset of type 1 diabetes (T1D). The study was published in Nature Communications.

The treatment available for type 1 diabetes since the 1920s is insulin therapy. Over the years ... ways before transplanting them. These genetic modifications make the cells undetectable to ...

Gene therapy developer CRISPR Therapeutics AG (CRSP) is navigating some regulatory and commercial dynamics. Its flagship gene ...

According to a CDC report published in 2024, diabetes among juveniles is becoming increasingly common. While preventing Type ...